Results

Total Results: 744 records

Showing results for "presence".

261. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_executive.pdf
     September 01, 2011 - listed it in this table, noted “No eligible studies identified,” and added a footnote indicating the presence … in remission maintenance of remission; however, small sample sizes in two of the studies and the presence

262. Clopidogrel after Drug-Eluting Stent Implantation: Is current practice sufficient (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stent-clopidogrel-practice_research.pdf
     March 01, 2009 - were assigned to DES, since subsequent antiplatelet therapy requirements would be based on the presence … Estimation of Cumulative Incidence in the Presence of Competing Risks.

263. The Magnitude of Small-Study Effects in the Cochrane Database of Systematic Reviews: an Empirical Study of Nearly 30 000 Meta-analyses | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/grant-manuscripts/cochrane-database-abstract

264. Quantitative Synthesis: Learning Objectives and Recommendations (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-learning-objectives-recommendations.pdf
     July 01, 2019 - Unmitigated Failure’ Number-Needed-to-Treat-Related Concepts for Assessing Treatment Efficacy in the Presence

265. Treatments for Acute Pain: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-protocol-acute-pain-treatments.pdf
     August 08, 2019 - provide a meaningful combined estimate.46 The decision to conduct quantitative synthesis will depend on presence … age, sex, race/ethnicity, socioeconomic status, prior use of opioids], duration or severity of pain, presence

266. Cervical Ripening in the Outpatient Setting (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ocr-protocol-final_1.pdf
     December 18, 2019 - Influence of midwifery presence in United States centers on labor care and outcomes of low‐risk parous … Midwifery presence in United States medical centers and labor care and birth outcomes among low-risk

267. Systematic Review on Noninvasive Nonpharmacological Treatment for Chronic Pain: Surveillance Report 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-2-noninvasive-nonpharma.pdf
     April 01, 2022 - In addition, Key Question 6 addressed whether estimates of benefits and harms differ by age, sex, presence … B-1 Key Question 6: Do estimates of benefits and harms differ by age, sex, presence of comorbidities … B-2 Key Question 6: Do estimates of benefits and harms differ by age, sex, presence of comorbidities

268. Cervical Degenerative Disease Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cervical-degenerative-protocol.pdf
     January 12, 2022 - cervical disease (incidence 18.9% for females, 13.1% for males between 2006 and 2012).2 However, the presence … also situations where the observational evidence may be upgraded (e.g., large magnitude of effect, presence

269. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_disposition-comments.pdf
     October 01, 2010 - Discussion Age, sex and the presence of structural heart disease: “There is a high level of evidence … that age, sex, and the presence of structural heart disease are not associated with AF recurrence”. … The studies found little or no association between presence of structural heart disease and recurrence

270. Infectious Disease Including HIV/AIDS #09 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1412.pdf
     December 22, 2014 - GeneXpert® real-time polymerase chain reaction (PCR) system.94 The test simultaneously detects the presence … sample is detected by five separate real-time PCR fluorescent probes, which are activated in the presence … by amplicon contamination.95 The assay is intended to yield results in about 2 hours for both the presence … Besides identifying the presence of TB, the Xpert MTB/RIF test would also give a preliminary indication … outcomes: Current TB diagnostic methods are lengthy, taking days to weeks to confirm or rule out the presence

271. Infectious Disease Including HIV/AIDS #09 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1506.pdf
     December 01, 2015 - GeneXpert® real-time polymerase chain reaction (PCR) system.106 The test simultaneously detects the presence … sample is detected by five separate real-time PCR fluorescent probes, which are activated in the presence … by amplicon contamination.107 The assay is intended to yield results in about 2 hours for both the presence … Besides identifying the presence of TB, the Xpert MTB/RIF test also gives a preliminary indication … outcomes: Available TB diagnostic methods are lengthy, taking days to weeks to confirm or rule out the presence

272. C-Diff-Infections-Surveillance-140925 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections-surveillance-140925.pdf
     January 01, 2014 - analysis56 found that fidaxomicin was more effective than vancomycin in achieving clinical cure in the presence … infection with negative enzyme immunoassay for toxin received a diagnosis of CDI based on the presence … difficile and the presence of the PCR ribotype 027 in stool samples. … Differences in fecal lactoferrin levels suggest variable presence or severity of C. difficile infection … vancomycin Candida species present before/after treatment; incidence in those who did not have presence

273. Version 2_Risk of Reinfection From SARS-CoV-2 -- An Update of an Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: A Living Rapid Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-2-risk-of-reinfection-from-SARSCoV2_0.pdf
     December 31, 2022 - (i.e., mild, moderate, severe, and critical as defined in NIH COVID-19 treatment guidelines)53 • Presence … at DCI Henry Avenue (Philadelphia, PA) Incidence of COVID-19 infection in the cohort; Link the presence … (seroconversion) from quantitative and qualitative testing; Incidence of COVID-19 reinfection; presence … patients from retirement homes and long-term care units Group 3: Staff of health care institutions Presence

274. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_executive.pdf
     June 01, 2011 - ACEIs, for example, do not entirely block production of angiotensin II because of the presence of unaffected

275. Newer Medications for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostatic-hyperplasia-medications_research-protocol.pdf
     April 21, 2015 - In light of this, and because the presence of BOO may modify treatment, bladder scans for urine volume … factors that may be considered in assessing strength of evidence include dose-response relationship, the presence

276. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd_research-protocol.pdf
     August 10, 2010 - In addition, we will evaluate the presence of additional biases, such as the funding bias.

277. Study Eligibility Criteria (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/study-eligibility-criteria.ppt
     January 01, 2000 - significant results, finding grey literature of unpublished nonsignificant or null results may indicate the presence

278. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-screening_research-protocol.pdf
     October 20, 2011 - We will use standard  2 tests to assess the presence of statistical heterogeneity among studies and

279. Opioid Treatments for Chronic Pain Research Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioid-treatments-chronic-pain-protocol.pdf
     December 19, 2018 - provide a meaningful combined estimate.20 The decision to conduct quantitative synthesis will depend on presence … factors (e.g., demographic characteristics, duration or severity of pain, underlying pain condition, presence

280. Methods Guide for Medical Test Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-metaanalysis_methods.pdf
     July 01, 2012 - measured against a “gold standard,” that is, a reference standard considered adequate to define the presence … Other than accounting for the presence of a “threshold effect,” the HSROC and bivariate models provide